GlassScriptPhysician profile
Sarah Isabel Fernandez
NPI 1861695843
$1,416.17
in general payments reported to CMS, 2019-2025
8 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $238 · 2021: $148 · 2022: $224 · 2023: $280 · 2024: $108 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $416.01 | 2019-2021 | |
| Smith+Nephew, INC. | $224.13 | 2020-2023 | Acticoat 4" X 4", Collagenase Santyl, Iodosorb Ointment 40g USA |
| Integra Lifesciences Corporation | $223.58 | 2022 | |
| Motiva USA, LLC | $172.94 | 2025 | |
| Kerecis Limited | $135.26 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $107.50 | 2024 | |
| Allergan, INC. | $103.60 | 2019 | |
| Reprise Biomedical, INC. | $33.15 | 2023 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.